01 1Nectar Lifesciences
01 1CEFPODOXIME PROXETIL USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-11-11
Pay. Date : 2014-06-18
DMF Number : 27071
Submission : 2014-06-14
Status : Active
Type : II
20
Nectar Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CEFPODOXIME PROXETIL USP, with a corresponding US DMF Number 27071.
Remarkably, this DMF maintains an Active status since its submission on June 14, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 11, 2014, and payment made on June 18, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
